Clinical Trial Update: Comparison Between Pioglitazone and SES With type2 DM [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial comparing pioglitazone to SES in patients with coronary artery disease and type 2 diabetes mellitus has completed. The document notes c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Showa University | Conditions: Coronary Artery Disease, Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED